Showing results (311-320 of 522) with videos related to
Sort By:
Pageof 53
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 9, 2013
Using remote substituents to control solution structure and anion binding in lanthanide complexesManuel Tropiano, Octavia A Blackburn, James A Tilney, et al.Multiple Sclerosis and Related Disorders|April 9, 2022
Repeat infusion of autologous bone marrow cells in progressive multiple sclerosis - A phase I extension study (SIAMMS II)Claire M Rice, Pamela Sarkar, Peter Walsh, et al.Cancer Medicine|August 23, 2019
Burden of hospitalization in acute lymphoblastic leukemia patients treated with Inotuzumab Ozogamicin versus standard chemotherapy treatmentDavid I Marks, Ilse van Oostrum, Sabrina Mueller, et al.Bone Marrow Transplantation|November 1, 1992
Orthotopic liver transplantation for hepatic GVHD following allogeneic BMT for chronic myeloid leukaemiaD I Marks, B Dousset, A Robson, et al.Hematology (Amsterdam, Netherlands)|July 12, 2008
The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation studyMaria H Gilleece, Rachel Pearce, David C Linch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemiaD I Marks, B W Kurz, M P Link, et al.Cancer|August 2, 2024
Inotuzumab ozogamicin in adult acute lymphoblastic leukemia: Development, current status, and future directionsHagop M Kantarjian, Nicolas Boissel, Cristina Papayannidis, et al.British Journal of Haematology|March 1, 1996
Analysis of p53 and mdm-2 expression in 18 patients with Sézary syndromeD I Marks, E C Vonderheid, B W Kurz, et al.Clinical Pharmacology and Therapeutics|May 7, 2010
Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosisC M Rice, E A Mallam, A L Whone, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2014
Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committeeJoseph Bubalo, Paul A Carpenter, Navneet Majhail, et al.Pageof 53